Study of Telitacicept in Generalized Myasthenia Gravis

Clinical trial NCT05737160 · COMPLETED

Trial details

NCT number: NCT05737160
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2023-03-28
Primary completion: 2024-11-26
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.